The latest rating and price-target changes from Wall Street analysts, newest first — the firm, the analyst, and the article each one was published in.
Average 12-month target $21.50 · Consensus Buy (13 analysts)
| Firm · analyst | Date | Rating | Price target | Source |
|---|---|---|---|---|
| JP Morgan | Nov 27, 2023 | DowngradeOverweight → Neutral | — | — |
| Canaccord Genuity | Nov 27, 2023 | MaintainsBuy | — | — |
| Baird | Nov 21, 2023 | DowngradeOutperform → Neutral | — | — |
| TD Cowen | Nov 20, 2023 | DowngradeOutperform → Market Perform | — | — |
| Morgan Stanley | Oct 24, 2023 | MaintainsEqual Weight | — | — |
| UBS | Oct 11, 2023 | MaintainsBuy | — | — |
| Canaccord Genuity | Sep 18, 2023 | MaintainsBuy | — | — |
| Morgan Stanley | Aug 6, 2023 | MaintainsEqual Weight | — | — |
| Baird | Aug 3, 2023 | MaintainsOutperform | — | — |
| Morgan Stanley | May 7, 2023 | MaintainsEqual Weight | — | — |
| Morgan Stanley | Mar 1, 2023 | MaintainsEqual Weight | — | — |
| UBS | Feb 2, 2023 | MaintainsBuy | $15.00 | Benzinga ↗ |
| Morgan Stanley | Nov 8, 2022 | MaintainsEqual Weight | — | — |
| Cowen & Co. | Nov 7, 2022 | MaintainsOutperform | — | — |
| Baird | Nov 7, 2022 | MaintainsOutperform | — | — |
Source: Wall Street analysts' published price targets and ratings, compiled by Financial Modeling Prep from Benzinga; as of Nov 15, 2026. Not FRC research or a recommendation.